Cagri+sema (2.5mg+2.5mg) × 10 Vials

Cagrilintide is a long‑acting amylin analogue that engages amylin and calcitonin receptors to delay gastric emptying and suppress glucagon. Sema. is a GLP‑1 receptor agonist that reduces gastric emptying, enhances insulin secretion. Sema. + cagrilintide together leverage dual‑hormone and triple‑hormone pathways.

Form: White to off‑white lyophilized powder
Blend Ratio Contains: 2.5 mg cagrilintide + 2.5 mg sema.
Purity: ≥ 99 % by reverse‑phase HPLC
Molecular Weights: Cagrilintide ~4300 Da; Sema. ~4115 Da
Half‑Lives: Cagrilintide ~1 week (by amylin analog kinetics); Sema. ~7 days
CAS Numbers: Cagrilintide: (not yet assigned); Sema.: 910463‑68‑2
Solubility: ≥ 25 mg/mL in water at 25 °C
Storage    −20 °C, desiccated, protected from light (stable ≥ 2 years)